MYDA Advisors LLC - LIANBIO ownership

LIANBIO's ticker is and the CUSIP is 53000N108. A total of 37 filers reported holding LIANBIO in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
MYDA Advisors LLC ownership history of LIANBIO
ValueSharesWeighting
Q3 2023$298,000
-5.2%
200,000
+45.1%
0.10%
+2.1%
Q2 2023$314,300
+33.6%
137,851
+14.9%
0.09%
+5.6%
Q1 2023$235,200
+6.2%
120,000
-11.1%
0.09%
-34.6%
Q4 2022$221,400
-7.8%
135,000
+12.5%
0.14%
+20.4%
Q3 2022$240,000
-7.3%
120,0000.0%0.11%
+56.9%
Q2 2022$259,000
-18.8%
120,000
+39.5%
0.07%
-42.9%
Q1 2022$319,000
+159.3%
86,000
+330.0%
0.13%
+281.8%
Q4 2021$123,00020,0000.03%
Other shareholders
LIANBIO shareholders Q1 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,282,084$4,929,0004.16%
Perceptive Advisors 56,560,211$122,170,0003.83%
SCHF (GPE), LLC 937,500$2,025,0002.99%
VR Adviser, LLC 5,378,341$11,617,0002.29%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 3,314,173$7,159,0000.52%
Affinity Asset Advisors, LLC 450,000$972,0000.41%
Altium Capital Management LP 315,191$681,0000.27%
RA Capital Management 4,622,574$9,985,0000.27%
22NW, LP 141,223$305,0000.16%
Logos Global Management LP 394,486$852,0000.16%
View complete list of LIANBIO shareholders